OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC326872 Human cDNA pCMV6-XL5 LEF1 (untagged)-Human lymphoid enhancer-binding factor 1 (LEF1) transcript variant 4 (10ug) NM_001166119.1 $580 3-4 weeks
RC228237 Human ORF PS100001 LEF1 (Myc-DDK-tagged)-Human lymphoid enhancer-binding factor 1 (LEF1), transcript variant 4, (10ug) $460 3-4 weeks
RC228237L1 Human ORF PS100064 Lenti-ORF clone of LEF1 (Myc-DDK-tagged)-Human lymphoid enhancer-binding factor 1 (LEF1), transcript variant 4, (10ug) $580 5-6 weeks
RC228237L2 Human ORF PS100071 Lenti-ORF clone of LEF1 (mGFP-tagged)-Human lymphoid enhancer-binding factor 1 (LEF1), transcript variant 4, (10ug) $660 5-6 weeks
RG228237 Human ORF PS100010 LEF1 (GFP-tagged) - Human lymphoid enhancer-binding factor 1 (LEF1), transcript variant 4, (10ug) $510 3-4 weeks
TF303556 Human shRNA pRFP-C-RS LEF1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $650 7-9 Days
TG303556 Human shRNA pGFP-V-RS LEF1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR303556 Human shRNA pRS LEF1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $498 In Stock
/ UTR pMirTarget 3`UTR clone of lymphoid enhancer-binding factor 1 (LEF1) transcript variant 4 for miRNA target validation NM_001166119.1 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title